Do you really think Merck just signed a new deal without doing diligence?
Previous small trials were a good indicator. This trial of 750 is the real deal..........FDA want to see results over a large number of patients.
If we are looking at a PFS of 36 months then that takes us to late 2027. Perfect timing for an aquisition and Merck get their new patents and ongoing sales stream. We need to be a bit more patient ( i have owned since early PRR) as Merck are probably happy to string this out for 3 more years testing all options before their own Keytruda patent runs out.
Ann: Immutep completes institutional pro-rata offer & placement, page-13
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.060(20.3%) |
Mkt cap ! $515.6M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.5¢ | 33.5¢ | $6.427M | 18.03M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 133736 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |